Regulatory considerations for developing remote measurement technologies for Alzheimer's disease research.
- DOI
- 10.1038/s41746-024-01211-8
- Published
- 2024 Sep 4
- Container
- NPJ digital medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41746-024-01211-8,
title = {Regulatory considerations for developing remote measurement technologies for Alzheimer's disease research.},
author = {Erdemli G and Grammatikopoulou M and Wagner B and Vairavan S and Curcic J and Aarsland D and Wittenberg G and Nikolopoulos S and Muurling M and Froehlich H and de Boer C and Shanbhag NM and Nies VJM and Coello N and Gove D and Diaz A and Foy S and Dartee W and Brem AK},
year = {2024},
journal = {NPJ digital medicine},
doi = {10.1038/s41746-024-01211-8},
url = {https://doi.org/10.1038/s41746-024-01211-8}
}RIS
TY - JOUR TI - Regulatory considerations for developing remote measurement technologies for Alzheimer's disease research. AU - Erdemli G AU - Grammatikopoulou M AU - Wagner B AU - Vairavan S AU - Curcic J AU - Aarsland D AU - Wittenberg G AU - Nikolopoulos S AU - Muurling M AU - Froehlich H AU - de Boer C AU - Shanbhag NM AU - Nies VJM AU - Coello N AU - Gove D AU - Diaz A AU - Foy S AU - Dartee W AU - Brem AK PY - 2024 JO - NPJ digital medicine DO - 10.1038/s41746-024-01211-8 UR - https://doi.org/10.1038/s41746-024-01211-8 ER -
APA
G, E., M, G., B, W., S, V., J, C., D, A., G, W., S, N., M, M., H, F., C, D. B., NM, S., VJM, N., N, C., D, G., A, D., S, F., W, D., & AK, B. (2024). Regulatory considerations for developing remote measurement technologies for Alzheimer's disease research.. NPJ digital medicine. https://doi.org/10.1038/s41746-024-01211-8
Source records
- pubmed · retrieved 2026-09-25T13:24:55.625Z